Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States

Authors

Janetta L. Iwanicki, Denver Health and Hospital Authority, Denver
S. Geoff Severtson, Denver Health and Hospital Authority, Denver
Heather McDaniel, Denver Health and Hospital Authority, Denver
Andrew Rosenblum, National Development and Research Institutes, Incorporated, New York
Chunki Fong, National Development and Research Institutes, Incorporated, New York
Theodore J. Cicero, Washington University School of Medicine in St. Louis
Matthew S. Ellis, Washington University School of Medicine in St. Louis
Steven P. Kurtz, Nova Southeastern University, Fort Lauderdale
Mance E. Buttram, Nova Southeastern University, Fort Lauderdale
Richard C. Dart, Denver Health and Hospital Authority, Denver

Journal

PLoS One

Publication Date

2016

Volume

11

Issue

12

Inclusive Pages

e0167499

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0167499

Rights and Permissions

Iwanicki JL, Severtson SG, McDaniel H, Rosenblum A, Fong C, et al. (2016) Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States. PLOS ONE 11(12): e0167499. doi: 10.1371/journal.pone.0167499

Recommended Citation

Iwanicki, Janetta L.; Severtson, S. Geoff; McDaniel, Heather; Rosenblum, Andrew; Fong, Chunki; Cicero, Theodore J.; Ellis, Matthew S.; Kurtz, Steven P.; Buttram, Mance E.; and Dart, Richard C., "Abuse and diversion of immediate release opioid analgesics as compared to extended release formulations in the United States." PLoS One. 11, 12. e0167499. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5547